Epitope mapping of neutralizing TSST-1 specific antibodies induced by immunization with toxin or toxoids.
Toxic shock syndrome toxin-1 (TSST-1), a superantigen produced by Staphylococcus aureus, is a potent stimulator of the immune system. T-cells are activated by crosslinking of MHC class II molecules on antigen presenting cells with T-cell receptors (TCR). TSST-1 is associated with the majority of the cases of menstrual staphylococcal toxic shock, a severe and life-threatening multisystem disorder. Even though antibody mediated protection has been studied, information on antibody specificity directed to individual antigenic determinants of the protein is incomplete. To obtain immunogens with low toxicity, we generated a double-site mutant (dmTSST-1), modified at solvent-exposed residues predicted to be important for both MHC class II and TCR binding, and detoxified recombinantly expressed TSST-1 (rTSST-1) as well as native TSST-1 (nTSST-1) isolated from Staphylococcus aureus by treatment with formaldehyde. Rabbits were immunized with rTSST-1, nTSST-1, dmTSST-1, and formaldehyde inactivated toxoids. The sera obtained were used to map the antigen-reactive regions of the molecule and to identify specificities of antibodies induced by immunization with the different antigens. To detect linear antigenic epitopes of TSST-1 the reactivity of the sera with 11-meric peptides having an overhang of four residues, covering the entire molecule of TSST-1, have been studied. We found that sera of TSST-1 immunized rabbits predominantly reacted with N-terminal residues 1-15, while sera generated with formaldehyde inactivated toxoid recognized a total of 7 regions located at the N- and C-terminus and internal sites of TSST-1. Despite different specificities all sera were able to inhibit TSST-1 induced proliferation of human mononuclear cells.
Gampfer
Jörg M
JM
Biomedizinische Forschungsgesellschaft mbH, Schwarzspanierstrasse 15/1/19, A-1090, Vienna, Austria. joerg.gampfer@biomed-research.at
Samstag
Aysen
A
Waclavicek
Martina
M
Wolf
Hermann M
HM
Eibl
Martha M
MM
Gulle
Heinz
H
D000595:Amino Acid Sequence; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis* / Q000097:blood* / Q000737:chemistry; D000918:Antibody Specificity; D000942:Antigens, Bacterial / Q000097:blood / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D001427:Bacterial Toxins; D004768:Enterotoxins / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D018604:Epitope Mapping / Q000379:methods*; D005260:Female; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed / Q000235:genetics / Q000276:immunology; D020959:Polyethylene / Q000276:immunology / Q000378:metabolism; D020836:Protein Structure, Quaternary; D017434:Protein Structure, Tertiary; D011817:Rabbits; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology; D013209:Staphylococcal Vaccines / Q000008:administration & dosage / Q000276:immunology*; D018089:Superantigens; D014121:Toxoids / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000235:genetics
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001427:Bacterial Toxins; D004768:Enterotoxins; D011994:Recombinant Proteins; D013209:Staphylococcal Vaccines; D018089:Superantigens; D014121:Toxoids; D014614:Vaccines, Synthetic; C030107:enterotoxin F, Staphylococcal; D020959:Polyethylene